Systematically Assessing Changes in Plexiform Neurofibroma Related Disfigurement From Photographs of Subjects With Neurofibromatosis Type 1 on a Phase 2 Clinical Trial
CompletedOBSERVATIONAL
Enrollment
52
Participants
Timeline
Start Date
May 12, 2021
Primary Completion Date
August 15, 2022
Study Completion Date
August 15, 2022
Conditions
Neurofibromatosis 1
Trial Locations (1)
20892
National Institutes of Health Clinical Center, Bethesda